新西兰在药房投资604万新西兰元,为癌症和呼吸道疾病提供新治疗。 New Zealand invests $604M in Pharmac, securing new treatments for cancers and respiratory diseases.

新西兰政府已在药房投入了有史以来最大的投资,提供了6.04亿美元的增资,以增加药品供应。 The New Zealand government has made its largest-ever investment in Pharmac, providing a $604 million uplift to increase medicine availability. 这项投资使药房能够获得四种新药物,包括肺癌、转移性乳腺癌、高危婴儿的RSV和COPD的治疗。 This investment has allowed Pharmac to secure four new medicines, including treatments for lung cancer, metastatic breast cancer, RSV in high-risk infants, and COPD. 这一举动反映了对更加以病人为中心的保健系统的承诺。 The move reflects a commitment to a more patient-centered healthcare system.